Levetiracetam Alter

Levetiracetam, the active ingredient in Levetiracetam Alter, is an anticonvulsant (antiepileptic) presented as an oral dosage form for oral use. It is used to manage various seizure types in patients with epilepsy.

GNH USA supplies Levetiracetam Alter as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is an antiepileptic drug that reduces abnormal neuronal firing in the brain. It is indicated for several seizure disorders: - Partial onset seizures: decreases frequency of focal seizures. - Generalized tonic‑clonic seizures: helps prevent convulsive episodes. - Myoclonic seizures: reduces rapid, brief muscle jerks.

Levetiracetam may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects: - Dizziness: feeling light‑headed or unsteady. - Fatigue: persistent tiredness. - Headache: mild to moderate pain. - Irritability: mood changes or agitation. - Nausea: upset stomach. - Nasal congestion: blocked or runny nose.

Serious or Rare Side Effects: - Severe allergic reaction: rash, swelling, or difficulty breathing. - Mood disorders: depression or suicidal thoughts. - Hematologic abnormalities: low blood counts. - Hepatic dysfunction: elevated liver enzymes. - Skin reactions: Stevens‑Johnson syndrome. - Multiorgan failure: very rare systemic involvement.

Before initiating therapy, clinicians should consider several safety aspects. - Renal function: adjust dose in patients with impaired clearance. - Psychiatric history: monitor for mood changes or depression. - Concomitant CNS depressants: avoid excessive sedation. - Pregnancy: weigh benefits against potential risks; consult obstetric guidance. - Breastfeeding: assess infant exposure and possible effects. - Store at ambient temperature: keep below 25 °C, retain original packaging, protect from moisture.

Levetiracetam can interact with other medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam levels. - Phenobarbital: can reduce seizure control. - Rifampin: induces metabolism, decreasing drug exposure.

Moderate Interactions (Monitor Closely): - Valproic acid: may increase levetiracetam concentrations. - Oral contraceptives: potential reduction in hormonal efficacy. - Other antiepileptics: assess cumulative CNS effects.